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p63 cooperates with CTCF to modulate 
chromatin architecture in skin keratinocytes
Jieqiong Qu1†, Guoqiang Yi2,3† and Huiqing Zhou1,4* 
Abstract 
The transcription factor p63 regulates epidermal genes and the enhancer landscape in skin keratinocytes. Its molecu-
lar function in controlling the chromatin structure is, however, not yet completely understood. Here, we integrated 
multi-omics profiles, including the transcriptome, transcription factor DNA-binding and chromatin accessibility, in skin 
keratinocytes isolated from EEC syndrome patients carrying p63 mutations, to examine the role of p63 in shaping the 
chromatin architecture. We found decreased chromatin accessibility in p63- and CTCF-bound open chromatin regions 
that potentially contributed to gene deregulation in mutant keratinocytes. Cooperation of p63 and CTCF seemed to 
assist chromatin interactions between p63-bound enhancers and gene promoters in skin keratinocytes. Our study 
suggests an intriguing model where cell type-specific transcription factors such as p63 cooperate with the genome 
organizer CTCF in the three-dimensional chromatin space to regulate the transcription program important for the 
proper cell identity.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Skin development and homeostasis requires tightly regu-
lated epidermal keratinocyte proliferation, differentia-
tion and apoptosis, and these processes are governed by 
cooperation of cis-regulatory elements, transcription fac-
tors (TFs), chromatin accessibility as well as higher-order 
chromatin organization [1–5]. The TF p63 is a key regu-
lator of epidermal development. At the molecular level, 
p63 regulates a large number of genes, for example, p21 
(CDKN1A) in cell cycle arrest [6], Fras1 in maintaining 
basement membrane integrity [7] and key genes such as 
keratins, filaggrin and loricrin required for epidermal 
morphogenesis and differentiation [1, 8]. Furthermore, 
p63 directly regulates chromatin factors: Satb1, Lsh and 
Brg1, to control the chromatin remodeling during epi-
dermis development [9–11]. Recent studies showed that 
p63 exerts a crucial role in establishing the enhancer 
landscape [4, 5, 12, 13]. Through active enhancers, 
p63 cooperates with its co-regulating TFs to modulate 
transcriptional program required for epidermal homeo-
stasis [4].
In human, heterozygous mutations of TP63 encoding 
p63 cause a spectrum of ectoderm-related disorders [14]. 
For example, ectrodactyly–ectodermal dysplasia–cleft 
lip/palate (EEC) syndrome is caused by point mutations 
located in the p63 DNA-binding domain and manifests 
ectodermal dysplasia with defects in the epidermis and 
epidermal-related appendages, limb malformation and 
cleft lip/palate. Five hotspot mutations affecting amino 
acids, R204, R227, R279, R280 and R304, cover approxi-
mately 90% of the all EEC syndrome cases [15]. Our 
previous study showed that mutant p63 resulted in a 
genome-wide redistribution of enhancers in keratino-
cytes established from EEC patients [13]. Consist-
ently, the gene network analysis identified a significant 
co-expression gene module of ‘nucleosome assembly’, 
implying a less-organized chromatin structure in EEC 
syndrome keratinocytes [13]. How mutant p63 affects the 
chromatin structure is, however, not yet clear.
In this study, we characterized the chromatin accessi-
bility using ATAC-seq in keratinocytes established from 
EEC patients carrying p63 mutations, in comparison 
with control keratinocytes. A clear difference in chroma-
tin accessibility that correlated with the transcriptional 
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dynamics was detected. Unexpectedly, strong enrichment 
of CTCF binding sites was observed at control-specific 
open chromatin regions. By combining published pro-
moter capture Hi-C seq data, we found that CTCF and 
p63 were cooperatively involved in DNA loops to regu-
late epidermal genes. Our findings provide new insights 
into the coordinated regulatory role of CTCF and p63 in 
chromatin interactions in epidermal keratinocytes.
Results
Differential chromatin accessibility between control 
and p63 mutant keratinocytes
We performed assay for transposase-accessible chro-
matin with high-throughput sequencing (ATAC-seq) 
to characterize the accessible genome as well as the 
nucleosome position in both control and p63 mutant 
keratinocytes at the proliferation stage. Two replicas of 
ATAC-seq analyses showed high correlation (Fig.  1a), 
indicating high reproducibility. The principle component 
analysis (PCA) plot based on the chromatin accessibil-
ity displayed a clear separation between control and p63 
mutant keratinocytes (Fig.  1b), which is highly consist-
ent with results from gene expression profiles (Fig.  1b). 
The two p63 mutant lines showed high similarity in both 
genome accessibility and transcription level, as they are 
close on the PC1 axis that represents major variations. As 
the goal of this work is to examine the difference between 
control and EEC mutant lines, these two mutant lines 
were considered as one group, termed as p63 mutant 
keratinocytes, in the following analyses.
Subsequently, we identified the differential open chro-
matin regions (OCRs) marked by ATAC-seq signals 
between control and p63 mutant keratinocytes. In total, 
there were 2492 open chromatin regions that showed 
higher signal in control keratinocytes, termed as control-
specific open chromatin regions (Ctr-OCRs); in paral-
lel, there were 3716 regions that showed higher signal in 
mutant keratinocytes, termed as mutant-specific open 
chromatin regions (Mt-OCRs) (Fig.  1c). As expected, 
we found that differential OCRs were positively corre-
lated with gene expression, when they were assigned to 
the nearest differentially expressed (DE) genes (Fig.  1c). 
Genes associated with Ctr-OCRs were mainly involved in 
the regulation of ‘cell cycle’ (Fig. 1d), e.g., CDC7 (Fig. 1e), 
while genes nearby Mt-OCRs were mainly enriched in 
‘actin filament-based process’ (Fig. 1d), e.g., FAP (Fig. 1e).
p63 and CTCF occupancy at Ctr‑OCRs
To identify the potential TFs involved in these differ-
ential OCRs, we first performed a comparative motif 
analysis between control and p63 mutant keratinocytes 
using HOMER. Among the Ctr-OCRs, we found that p63 
motif is most enriched (Fig. 2a), which is consistent with 
our previous finding that loss of p63 binding resulted in 
decreased enhancers in p63 mutant keratinocytes [13]. 
Unexpectedly, the motif of CTCF that is a well-known 
genome organizer [16] was identified as the second 
highly enriched motif in the Ctr-OCRs. Among the Mt-
OCRs, AP-1 motif family was most enriched (Fig.  2b), 
consistent with findings on gained enhancers in p63 
mutant keratinocytes [13].
To validate our motif analysis result and explore the 
role of p63 in controlling Ctr-OCRs, we used published 
p63 ChIP-seq data from our previous work [13]. In con-
trol keratinocytes, a total of 1223 p63 binding sites (BSs) 
were covered by the 2492 Ctr-OCRs, showing a sig-
nificant overlap (p < 0.001). When ATAC-seq and p63 
ChIP-seq reads were mapped to the 1223 p63-bound Ctr-
OCRs, we found a decrease in both chromatin accessibil-
ity and p63 binding signals at the p63-bound Ctr-OCRs 
in p63 mutant keratinocytes (Fig. 2c).
To confirm the role of CTCF in Ctr-OCRs, we per-
formed CTCF ChIP-seq in both control and p63 mutant 
keratinocytes. In total, we found 12,116 CTCF BSs, 
among which only 363 were differential in CTCF binding 
between control and p63 mutant keratinocytes (p < 0.05), 
indicating that CTCF binding is rather stable. In addition, 
among all putative CTCF BSs, we found 376 overlapped 
with the 2492 Ctr-OCRs, which is statistically signifi-
cant (p < 0.001). We then mapped ATAC-seq and CTCF 
ChIP-seq reads to the 376 CTCF-bound Ctr-OCRs. As 
expected, decrease in ATAC-seq signals was observed 
at the CTCF-bound Ctr-OCRs in p63 mutant keratino-
cytes. However, unexpectedly, there was no significant 
change in CTCF binding signals at the CTCF-bound 
Ctr-OCRs in p63 mutant keratinocytes, as compared to 
the control keratinocytes (Fig.  2d). Another unexpected 
finding was that there is few overlap (n = 435) out of 
45,350 p63 BSs and 12,116 CTCF BSs (Additional file 1: 
Fig.  S1A), although both motifs were identified in Ctr-
OCRs. Consistently, there was no visible CTCF binding 
signal at all p63 BSs, and vice versa, no visible p63 bind-
ing at the CTCF BSs (Additional file 1: Fig. S1B). We also 
observed decreased p63 binding and largely unchanged 
CTCF binding signal in p63 mutant keratinocytes at the 
co-localized binding sites (Additional file 1: Fig. S1C).
Subsequently, we analyzed the nucleosome posi-
tioning at p63-bound and CTCF-bound Ctr-OCRs 
by mapping the distribution of ATAC-seq fragments 
centered on either p63 motif or CTCF motif (Fig.  2e). 
In control keratinocytes, we found an enrichment of 
short fragments (< 150 bp) surrounding both p63 motif 
and CTCF motif. The enrichment of such short reads 
clearly decreased in p63 mutant keratinocytes (Fig.  2e 
and Additional file  2: Fig.  S2). We also observed an 
enrichment of fragments that had lengths slightly 
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Fig. 1 Differential chromatin accessibility in p63 mutant keratinocytes. a A heatmap of sample correlation matrix showing high similarities between 
duplicates and dissimilarities between control (CTR) and p63 mutant keratinocytes (R204W and R304W). b PCA plots of ATAC-seq and RNA-seq of 
control and p63 mutant keratinocytes at the proliferation stage. c Upper panel, volcano plots of ATAC-seq comparisons between control and p63 
mutant keratinocytes. The x axis shows the log2 fold change of reads detected at the open chromatin regions (OCRs) and the y axis shows − log10 
(p value). Lower panel, the transcriptional changes of differentially expressed genes associated with differential OCRs indicated in the volcano plots. 
d GO annotation of differentially expressed genes nearby Ctr-OCRs and Mt-OCRs. e Examples of Ctr-OCRs and their associated DE gene, CDC7, as 
well as Mt-OCRs and their associated DE gene, FAP. ATAC-seq tracks are shown in the RPKM scale
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Fig. 2 Decreased chromatin accessibility and altered nucleosome organization at p63-bound OCRs and CTCF-bound OCRs in p63 mutant 
keratinocytes. a Top enriched motifs in Ctr-OCRs. 2492 Ctr-OCRs (targets) were used in this analysis with Mt-OCRs as background (bg). b Top 
enriched motifs in Mt-OCRs. 3716 Mt-OCRs (targets) were used in this analysis with Ctr-OCRs as background (bg). c Bandplots (top) and heatmaps 
(bottom) showing the quantification of ATAC-seq and p63 ChIP-seq signals at the 1223 p63-bound Ctr-OCRs. d Bandplots (top) and heatmaps 
(bottom) showing the quantification of ATAC-seq and CTCF ChIP-seq signals at the 376 CTCF-bound Ctr-OCRs. e V-plot of ATAC-seq reads showing 
the read length and distance from either p63 motif (top) or CTCF motif (bottom) in control and p63 mutant keratinocytes. The short fragments 
(< 150 bp) were indicative of nucleosome free DNA
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shorter than 200 bp which represent the stable flanking 
nucleosomes in control keratinocytes. However, in p63 
mutant keratinocytes, the approximate 200  bp length 
fragments seemed to be less present (Additional file 2: 
Fig. S2), indicating an altered nucleosome organization.
Taken together, we observed decreased accessibility at 
p63-bound and CTCF-bound Ctr-OCRs in p63 mutant 
keratinocytes when compared to control keratinocytes. 
Notably, there was a clear decrease in p63 binding at 
the p63-bound Ctr-OCRs, whereas CTCF binding did 
not seem to be affected at the CTCF-bound Ctr-OCRs 
in p63 mutant keratinocytes.
Characterization of p63‑bound OCRs and CTCF‑bound 
OCRs
We reasoned that the chromatin states and the genomic 
locations of these Ctr-OCRs might be informative to 
understand the difference between p63-bound and 
CTCF-bound Ctr-OCRs. To this end, we firstly ana-
lyzed the chromatin states (CSs) of all CTCF and p63 BSs 
with the combination of six histone marks from Road-
map project [17] (Fig. 3a). We found that p63 bound to 
both promoters and enhancers marked by H3K27ac and 
H3K4me1, whereas CTCF was more enriched at promot-
ers marked by H3K4me3 (Fig.  3a and Additional file  3: 
Fig. 3 Chromatin state and locations of p63- and CTCF-bound OCRs. a Fold enrichment/depletion of chromatin states (CSs) in p63 BSs and CTCF 
BSs compared to the randomized sequences. The 18 CSs were defined using ENCODE data [17]. b Relative enrichment (> 1)/depletion (< 1) of CSs in 
p63-bound Ctr-OCRs and CTCF-bound Ctr-OCRs compared to all Ctr-OCRs. The circle size represents the percentage of either p63-bound Ctr-OCRs 
(left) or CTCF-bound Ctr-OCRs (right) in each CS. Relative score is calculated by comparing odds ratios between two overlap tests, in which odds 
ratio is estimated by BEDtools fisher option. c Percentage of different loop types defined in the PCHiC data. d Size distribution of promoter–
enhancer loops in the PCHiC data. e Estimated enrichment of CTCF and p63 at promoters, enhancers, or TAD Boundary compared to the reshuffled 
sequences (CTR). Odds ratio indicates the enrichment (> 1)/depletion (< 1) of two independent peak lists calculated by BEDtools fisher option
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Fig.  S3). We then performed analyses on the p63- and 
CTCF-bound Ctr-OCRs (Fig.  3b). When comparing to 
all Ctr-OCRs, p63-bound Ctr-OCRs were overrepre-
sented at enhancers (CSs 8, 9 and 11), while the majority 
of CTCF-bound Ctr-OCRs showed overrepresentation at 
promoter-proximal regions (CSs 2 and 4, Fig.  3b), con-
sistent with all p63 and CTCF BSs.
Next, to analyze the localization of p63-bound and 
CTCF-bound Ctr-OCRs in regulatory chromatin inter-
actions, we utilized the promoter capture Hi-C (PCHiC) 
data and TAD (topologically associating domain) regions 
from published Hi-C data in keratinocytes [18]. In the 
PCHiC, promoters were used as baits to capture the 
interacting genomic regions. In total, this PCHiC dataset 
captured 119,648 interactions, including 103,497 (86.5%) 
promoter–enhancer loops and 16,151 (13.5%) promoter–
promoter loops (Fig. 3c). As p63 plays a more prominent 
role at enhancers (Fig. 3a) [4], we focused on promoter–
enhancer loops. These loops had a median loop size of 
250.9  kb (Fig.  3d). Among the previously defined 1223 
p63-bound Ctr-OCRs (Fig. 2c), 388 of them were located 
at the anchors of 1674 loops, at either the promoter or 
the enhancer, and on average one p63-bound Ctr-OCR 
was connected by ~ 4.3 loops. Similarly, among the 376 
CTCF-bound Ctr-OCRs (Fig.  2d), 191 of them were 
located at the anchors of 1093 loops; on average, one 
CTCF-bound Ctr-OCR was connected by ~ 5.7 loops. 
Therefore, CTCF-bound Ctr-OCRs at anchors were con-
nected by more loops.
Furthermore, we found that CTCF-bound Ctr-OCRs 
located at loop anchors were more enriched for promot-
ers (fourfold) (Fig. 3e), consistent with all CTCF BSs and 
all CTCF Ctr-OCRs. In contrast, p63-bound Ctr-OCRs 
associated with loops were enriched in both promot-
ers and enhancers to a similar extent (Fig.  3e), which is 
different from all p63 BSs and all p63-bound Ctr-OCRs 
that were only enriched at enhancers (Fig.  3b). We also 
examined whether p63- and CTCF-bound Ctr-OCRs 
were localized at the TAD boundaries. As expected, 
CTCF-bound Ctr-OCRs showed ~ 2.5-fold enrichment 
for TAD boundaries, whereas p63-bound Ctr-OCRs were 
depleted of TAD boundaries (Fig.  3e). Randomization 
by reshuffling genomic regions with same sizes did not 
show any enrichment in TAD boundaries, promoters or 
enhancers. As CTCF-bound Ctr-OCRs were enriched at 
the promoters and p63-bound Ctr-OCRs were enriched 
at both promoters and enhancers, it is plausible that p63-
bound enhancers interact with CTCF-bound promoters 
to regulate genes through DNA looping and a subset of 
these loops may be affected by p63 mutations.
p63 and CTCF mediate a subset of loops to regulate 
transcription
To assess how p63 and CTCF cooperates via DNA loop-
ing to regulate gene expression, we performed further 
analyses using previously published gene expression data 
[13] to examine the relation between gene expression and 
DNA looping. In control keratinocytes, we defined highly 
expressed genes by quartiles to four groups using their 
transcriptional levels (Q1-4, FPKM ≥ 1), and another 
group with lowly expressed genes (Q0, FPKM < 1). We 
detected an increasing number of associated loops with 
elevated gene expression levels (Fig.  4a). This suggests 
that highly expressed genes may be more indispensable 
of regulation through loops, which is line with previous 
study showing multi-loop activation hubs at key regula-
tory genes [19]. Moreover, the differentially expressed 
genes between control and p63 mutant keratinocytes 
(Fig.  1b) were associated with significantly more loops 
(p < 0.001) than all expressed genes (Fig. 4b). We also per-
formed the same analysis among loops with either p63-
bound or CTCF-bound Ctr-OCRs. Similar results were 
found, although in these comparisons the difference was 
not significant, probably due to the low number of asso-
ciated loops (Fig. 4c, d).
Fig. 4 p63- and CTCF-bound Ctr-OCRs are involved in chromatin loops regulating epidermal genes. a Highly expressed genes are associated 
with more DNA loops. Genes were divided in quarters according to their expression levels in keratinocytes. The number of connected DNA loops 
associated with each group of genes were plotted in the bottom bar chart. b DE genes were associated with more connected DNA loops when 
compared to all expressed genes. ***, p < 0.001, Wilcoxon signed-rank test. c DE genes were associated with more connected DNA loops with 
p63-bound Ctr-OCRs when compared to all expressed genes. d DE genes were associated with more connected DNA loops with CTCF-bound 
Ctr-OCRs when compared to all expressed genes. e Overlapping of genes mapped by CTCF-bound Ctr-OCRs (orange) and p63-bound Ctr-OCRs 
(blue). f GO annotation of the 96 genes potentially co-regulated by p63 and CTCF. g p63-bound and CTCF-bound Ctr-OCRs were involved in 
the same or different loops connecting the promoters of the 96 genes. 60 genes were regulated by the same loops with both p63-bound and 
CTCF-bound Ctr-OCRs: (1) in 12.6% cases, p63-bound Ctr-OCR located at one anchor while CTCF-bound Ctr-OCR located at the other anchor of the 
loop; in the majority cases, p63-bound and CTCF-bound Ctr-OCRs were both present at the (2) promoter (70.6%) or (3) enhancer (16.8%) of the DNA 
loops. h The left 36 genes were co-regulated by connecting DNA loops with p63-bound and CTCF-bound Ctr-OCRs at enhancers of different loops. 
i PIGV is shown as an example of G (1), which is connected by the DNA loop pair1402, bridging the PIGV promoter (with a CTCF-bound Ctr-OCR) 
and a distal enhancer (with a p63-bound Ctr-OCR). j KRT5 is shown as an example of G (3), which is connected by the DNA loop pair25496, bridging 
the KRT5 promoter and a distal enhancer (with both CTCF-bound and p63-bound Ctr-OCRs). The blue arrows pointed to the p63 BSs while the 
green arrows pointed to the CTCF BSs
(See figure on next page.)
Page 7 of 13Qu et al. Epigenetics & Chromatin           (2019) 12:31 
We then mapped 388 p63-bound and 191 CTCF-
bound Ctr-OCRs which are located at loop anchors to 
their target genes by identifying their interacting gene 
promoters located at anchors of the other end of the 
loops. In some cases, Ctr-OCRs were located in promot-
ers, and the associated genes were considered as target 
genes. In total, 388 p63-bound Ctr-OCRs interacted with 
304 gene promoters, while 191 CTCF-bound Ctr-OCRs 
interacted with 500 gene promoters through looping 
interactions, indicating that on average a CTCF-bound 
Ctr-OCR is involved in the regulation of more genes than 
a p63-bound Ctr-OCR. There was a significant (p < 0.001) 
overlap (n = 96) of genes that were potentially regulated 
by p63- and CTCF-bound Ctr-OCRs (Fig.  4e). These 
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96 genes represent genes connected by the promoter–
enhancer loops that were anchored by both p63-bound 
and CTCF-bound Ctr-OCRs and that may be affected 
in p63 mutant keratinocytes. As the three-dimensional 
chromatin landscape is relatively stable, we reasoned that 
the difference of the chromatin landscape in control and 
p63 mutant keratinocytes may influence gene expression 
during keratinocyte differentiation [18]. Therefore, we 
examined the expression of these 96 genes using previ-
ously reported differential gene expression in control 
and p63 mutant keratinocytes during differentiation [13]. 
Indeed, we found that 39 of these 96 genes showed dereg-
ulation (p < 0.001). Notably, many of the 96 genes were 
involved in ‘epidermal cell differentiation,’ e.g., KRT5, 
KRT75 and B9D1 (Fig. 4f ).
Next, we dissected how p63-bound and CTCF-bound 
Ctr-OCRs at loop anchors co-regulated these 96 genes: 
whether p63-bound and CTCF-bound Ctr-OCRs were 
involved in the same or different promoter–enhancer 
loops. We found that 60 genes were regulated by pro-
moter–enhancer loops where p63-bound and CTCF-
bound Ctr-OCRs were both located at the anchors in 
the same loops, although they may co-localize in differ-
ent manner (Fig. 4g). Among these 60 genes, 26 showed 
differential expression between control and p63 mutant 
keratinocytes during differentiation, with PIGV and 
KRT5 shown as examples (Fig.  4i, j). Among the loops 
associated with the 60 genes, the case where p63-bound 
Ctr-OCR was located at one anchor, while CTCF-bound 
Ctr-OCR was located at the other anchor of the loop 
counted for 12.6% (Fig.  4g, (1)). In the majority of the 
cases, both p63-bound and CTCF-bound Ctr-OCRs were 
present either at the promoter (70.6%) (Fig. 4g, (2)) or at 
the enhancer (16.8%) (Fig.  4g, (3)). Interestingly, for the 
rest 36 genes gene promoters were connected with both 
p63-bound and CTCF-bound Ctr-OCRs from different 
loops (Fig.  4h), suggesting that enhancers occupied by 
p63-bound and CTCF-bound Ctr-OCRs can co-regulate 
the same gene through different loops. Among these 36 
genes, 13 were deregulated in p63 mutant keratinocytes 
during differentiation.
Discussion
Over the years, molecular understanding of p63 function 
in keratinocytes has led to the identification of numer-
ous target genes including chromatin factors [20–22] as 
well as of a solid role of p63 in orchestrating the enhancer 
landscape [4, 5, 23]. However, whether p63 is involved 
in the direct regulation of chromatin architecture is not 
known. In this study, we characterized the chromatin 
accessibility with ATAC-seq in both control and EEC 
syndrome patient keratinocytes carrying p63 mutations 
(R204W and R304W). Interestingly, we found decreased 
chromatin accessibility in p63- and CTCF-bound open 
chromatin regions in mutant p63 keratinocytes. These 
less accessible chromatin regions interact with epidermal 
gene promoters and potentially regulate gene expres-
sion. Collectively, we proposed an unreported role of p63 
cooperating with CTCF in chromatin interactions.
It is envisaged that p63 is a key factor in skin keratino-
cytes [4, 5, 24]. Ample studies have shown that the proper 
regulation of gene expression by p63 through the precise 
control of enhancers is essential for maintaining the epi-
dermal cell identity [4, 13, 25, 26]. It is equally important 
that p63 requires additional co-regulating TFs to regulate 
transcription. Several studies reported p63 co-regulating 
TFs, e.g., AP1, AP2, STAT5 and RFX5 [20, 22, 23, 27], 
which are essential for the epidermal gene expression in 
a temporal and spatial manner [4, 28]. Besides, p63 inter-
acts with the chromatin remodeling factor BAF1 to main-
tain the open chromatin regions [5] and with Dnmt3a to 
locate enhancers [12]. In this study, we found that CTCF, 
a well-known TF maintaining the chromatin architec-
ture, is also a p63 co-regulating TF modulating a subset 
of chromatin loops. However, this cooperation is prob-
ably not through direction protein–protein interactions 
but mainly through  bridging enhancers and promoters, 
given the few overlap observed between p63 and CTCF 
BSs. It is known that the majority of p63-bound regions 
are located in intergenic or intragenic regions (enhanc-
ers) rather than promoters [22], and therefore, how p63-
bound enhancers interact with gene promoters is an 
interesting question. Our current study provides the first 
line of evidence that the cooperation with CTCF assists 
the looping of p63-bound enhancers to gene promoters.
The observation of the enriched CTCF motif in Ctr-
OCRs detected in our ATAC-seq analyses was somewhat 
unexpected. Our previous enhancer-centered analysis 
that focused on H3K27ac enriched genomic regions did 
not capture CTCF motifs [4, 13], probably due to the fact 
that CTCF is more enriched in open chromatin regions 
depleted of H3K27ac but enriched for H3K4me3 sig-
nal that are often promoters (Fig. 3a and Additional file 3: 
Fig. S3). Interestingly, detecting the CTCF motif in Ctr-
OCRs in keratinocytes is in line with the previous find-
ing that the motif of YY1 was enriched in p63-bound 
sequences [27]. YY1 has been shown to co-localize with 
CTCF and stabilize chromatin looping [29, 30].
CTCF maintains the genome organization by occu-
pying the boundaries of megabase-scale TADs and 
functions as an insulator to block enhancer–promoter 
interactions between different TADs [16]. Our data 
showed that, in addition to demarcating TADs, CTCF 
mediates promoter–enhancer loops, often located in 
promoter-proximal regions (Fig. 3e), to facilitate the pro-
moter–enhancer interactions within one TAD. This is in 
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line with the concept that a subpopulation of CTCF asso-
ciates with the RNA polymerase II (Pol II) protein com-
plex to activate transcription [31]. It is likely that CTCF 
helps to bridge the p63-bound enhancers to transcription 
start site-proximal regulatory elements and to initiate 
transcription by interacting with Pol II, thus supporting 
a role of CTCF in facilitating contacts between transcrip-
tion regulatory sequences. This model has been demon-
strated by the previous work on the beta-globin locus 
[32]. To get a clearer picture, technologies that are similar 
to ChIA-PET [33], such as HiChIP [34], would be useful 
to understand long-range contacts associated with CTCF 
or p63 in skin keratinocytes.
The three-dimensional chromatin landscape is rela-
tively stable once established in a specific cell type, 
probably during cell commitment, and cell type-specific 
looping structures mainly control the accessibility of 
enhancers to their specific targets [35]. Recent studies 
showed that cell type-specific TFs are involved in regula-
tion of DNA looping in macrophage development, neu-
ral development  as well as  during cell reprogramming, 
which shed light on the role of cell type-specific TFs in 
regulating chromatin interactions [19, 36, 37]. Here, we 
proposed that a number of loci nearby epidermal genes 
were organized into a ‘regulatory chromatin hub’ within 
the chromatin interactions mediated by CTCF in epider-
mal keratinocytes (Fig.  5a). Such hubs contain multiple 
connecting DNA loops that require not only CTCF bind-
ing that is rather static but also binding of cell type-spe-
cific TFs (e.g., p63) for the transcriptional activity. In this 
model, cell type-specific TFs may be essential to make 
the DNA loops active in transcription. This hypothesis 
is consistent with our observation that unchanged CTCF 
binding signal but decreased accessibility in the CTCF-
bound Ctr-OCRs in p63 mutant keratinocytes (Fig. 2d).
Moreover, our observations shed light on the chroma-
tin-based mechanisms underlying EEC syndrome caused 
p63 mutations. These EEC mutations, such as R204W 
and R304W, were shown to disrupt p63 DNA-binding, 
resulting in impaired transactivation activity and loss 
of epidermal cell identity [13, 38, 39]. Our data suggest 
that deregulated function of DNA loops mediated by p63 
and CTCF represents an additional layer to the disease 
mechanism (Fig.  5b). Given that CTCF binding did not 
change, it is likely that the looping interactions are static, 
but the looping is no longer active due to the absence of 
p63 binding (Fig. 5b (1)). Therefore, the epidermal genes 
were down-regulated and p63 mutant keratinocytes 
showed loss of epidermal cell identity [13]. On the other 
hand, it is also possible that the loop ablation as a result 
of lost p63 binding leads to the decreased accessibility at 
CTCF-bound promoters and deregulated gene expres-
sion in p63 mutant keratinocytes (Fig. 5b (2)). The latter 
scenario suggests that p63 is the key factor determin-
ing the regulatory activity of such promoter–enhancer 
interactions. Nevertheless, how p63 mutations affect the 
cooperation between p63 and CTCF and gene expression 
is still unclear. Among the 96 genes with loops connected 
by p63- and CTCF-bound Ctr-OCRs, only 39 of them 
were deregulated in p63 mutant keratinocytes. It is possi-
ble that ‘shadow enhancers’ that are composed of clusters 
of enhancer and contribute to robust gene transcription 
[40, 41], are involved in regulation of the 57 genes that 
are not deregulated in mutant keratinocytes. Further 
experiments are required to test these hypotheses.
Fig. 5 Models of how p63 and CTCF co-mediate chromatin loops regulating epidermal genes. a In control keratinocytes, p63 and CTCF co-mediate 
a subset of DNA loops nearby epidermal genes and regulate their gene expression. b In p63 mutant keratinocytes, due to the loss of p63 binding, 
p63 and CTCF co-mediated DNA loops are not functional anymore, and therefore epidermal genes are deregulated. There are two possibilities in 
deregulated function of looping: (1) the looping structure is stable as CTCF binding is unchanged; (2) the looping structure is partially changed 
because of loss of p63 binding and loss of the p63-dependent loop
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Taken together, our results highlight the cooperation of 
p63 and CTCF in mediating DNA loops as well as gene 
regulation. These observations provide new insights into 
the general regulatory role of chromatin looping which 
depends on the coordination of CTCF and cell type-spe-
cific TFs such as p63 in skin keratinocytes.
Materials and methods
Ethics statement
All procedures for establishing and maintaining human 
primary keratinocytes were approved by the ethical com-
mittee of the Radboud university medical center (“Com-
missie Mensgebonden Onderzoek Arnhem-Nijmegen”). 
Informed consent was obtained from all donors of a skin 
biopsy.
Human primary keratinocyte culture
Primary keratinocytes were established previously from 
skin biopsies of three EEC syndrome patients carry-
ing heterozygous mutations in the p63 DNA-binding 
domain, R204W [42] and R304W [39], as well as of 
non-EEC volunteers (Dombi23, referred to as control) 
[43]. R204W and R304W are treated as a p63 mutant 
group for further analyses to minimize the effect from 
individual difference. As previously described [44], pri-
mary keratinocytes were cultured in Keratinocyte Basal 
Medium (KBM, Lonza #CC-4131) supplemented with 
100 U/mL penicillin/streptomycin (Gibco Life Technol-
ogy #15140122), 0.1  mM ethanolamine (Sigma-Aldrich 
#141-43-5), 0.1  mM O-phosphoethanolamine (Sigma-
Aldrich #1071-23-4), 0.4% (vol/vol) bovine pituitary 
extract, 0.5 μg/mL hydrocortisone, 5 μg/mL insulin and 
10  ng/mL epidermal growth factor (Lonza #CC-4131). 
Medium was refreshed every other day. When cells were 
more than 90% confluent, cells were collected at the pro-
liferation stage. No mycoplasma contamination is found 
during cell culture.
ATAC‑seq
ATAC libraries of the control and p63 mutant keratino-
cytes were prepared by a documented protocol [45]. In 
brief, keratinocytes were treated with  Accutase® solu-
tion on plates and well re-suspended into single cells. 
Pellet cells for 5 min at 500 g. After twice wash with ice-
old PBS, pellet the cells again. Re-suspend cells and take 
out 100,000 cells for lysis with ice-old freshly made lysis 
buffer (containing 10 mM Tris–HCl pH 7.5, 10 mM NaCl, 
3 mM  MgCl2 and 0.1% IGEPAL CA-630 detergent). Then 
perform tagmentation using 2  μL of Tn5 transposase 
and 12.5  uL 2 × TD buffer (Illumina #FC-121-1031) at 
37  °C for 1  h with 650  rpm shaking. The resulted DNA 
fragments underwent two sequential seven-cycle PCR 
amplifications, and in between the libraries were selected 
for < 500 bp fragments using SPRI beads. The final PCR 
products were purified with QIAquick PCR Purification 
Kit (QIAGEN #28106) and quantified with the KAPA 
Library Quantification Kit (Kapa Biosystems #KK4844), 
and then sequenced in a paired-ended manner using the 
NextSeq  500 (Illumina) according to standard Illumina 
protocols.
CTCF ChIP‑seq
Chromatin for ChIP was prepared as previously 
described [20]. ChIP assays were performed following 
a standard protocol [46] with minor modifications. On 
average, 0.5  M keratinocytes were used in each ChIP. 
4x ChIP reactions are pooled to prepare one ChIP-seq 
sample. Antibodies against CTCF (Millipore #07-729, 
5uL) were used in each ChIP assay. Resulted DNA frag-
ments from four independent ChIP assays were purified 
with QIAquick PCR Purification Kit (QIAGEN #28106). 
Afterward, 5  ng DNA fragments were pooled and pro-
ceeded on with library construction using KAPA Hyper 
Prep Kit (Kapa Biosystems #KK8504) according to the 
standard protocol. The prepared libraries were then 
sequenced using the NextSeq 500 (Illumina) according to 
standard Illumina protocols.
RNA‑seq data analysis
Paired-end RNA-seq reads were mapped to the human 
genome hg19 using STAR aligner [47] in two-pass mode 
with default parameters and enumerate stranded gene-
level read counts at the same time. The generated count 
matrix was used as input for DESeq 2 package [48] to dis-
tinguish differential expressed genes between control and 
mutant keratinocytes. These genes greater than 1.5-fold 
changed at adjusted p value < 0.05 were considered sig-
nificantly deregulated.
ChIP‑seq and ATAC‑seq data analysis
Sequenced reads were aligned against the UCSC hg19 
human reference genome with Burrows–Wheeler Aligner 
(BWA) program with default parameters [49]. The poten-
tial PCR and optical duplicates were removed using Pic-
ard MarkDuplicates option. The filtered BAM files were 
inputted to MACS2 [50] for peak calling. The p63 ChIP-
seq data were published and re-analyzed in this study 
[13]. The p63, CTCF and H3K27ac were called using 
the narrow setting (default) with a q value of 0.01. For 
ATAC-seq, the open chromatin regions were predicted 
using default parameters except for using -f BAMPE 
option. Peaks overlapping with the consensus excludable 
ENCODE blacklist were dropped to avoid confounding 
by repetitive regions. All alignment files were extended 
to 200-bp and scaled to RPKM-normalized read coverage 
files using deepTools [51] for visualization. To compare 
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binding profiles between different samples unbiasedly, we 
applied library size factors estimated from DESeq2 [48] 
on RPKM values.
Differentially accessible regions were detected using 
DESeq 2 package [48] with fold change less than 2.0 and 
p value below 0.05. Differential motif analysis in the dif-
ferential DHSs was employed by the findMotifs function 
in HOMER tool (http://homer .salk.edu/homer /motif /) 
with other default parameters, which can normalize the 
background sequences to remove GC-bias. The BEDtools 
suite (https ://bedto ols.readt hedoc s.io/en/lates t/conte nt/
bedto ols-suite .html) was used to test overlap and enrich-
ment between different intervals.
Dimensionality reduction and functional annotation
For visualization, top 1000 variable genes were first 
selected based on interquartile range (IQR) of normalized 
expression values, and further used to reduce dimension-
ality (principal component analysis) of the dataset by pca 
function in R. Functional enrichment was evaluated by 
Metascape online tool [52], to gain insight into the bio-
logical functions for deregulated genes. Only these func-
tional terms with Benjamini-adjusted p value < 0.05 were 
considered significantly overrepresented.
Capture Hi‑C data processing
Raw promoter capture Hi-C sequencing reads from 
GSE84662 were processed using the HiCUP pipeline [53], 
like quality control, alignment to hg19 and reads filtering. 
Technical replicates were merged and de-duplicated, and 
then, pooled biological replicates were then jointly used 
for interaction identification with CHiCAGO [54] and 
the associated chicagoTools suite. All significant interac-
tions were defined based on a strict interaction threshold 
(CHiCAGO score ≥ 5).
Briefly, CHiCAGO predicts interactions based on a 
convolution background model reflecting both ‘Brown-
ian’ (real, but expected interactions) and ‘technical’ (assay 
and sequencing artifacts) components. The putative p 
values are corrected using a weighted false discovery con-
trol procedure that specifically accommodates the fact 
that increasingly larger numbers of tests are performed 
at regions where progressively smaller numbers of inter-
actions are expected. The weights were learned based on 
the decrease in the reproducibility of interaction calls 
between the individual replicates of macrophage samples 
with distance. Interaction scores were then computed for 
each fragment pair as log-transformed, soft-thresholded, 
weighted p values.
Additional files
Additional file 1: Figure S1. Few overlap between p63 and CTCF binding 
sites. A Overlapping of p63 and CTCF binding sites from ChIP-seq data. B 
Heatmaps showing the CTCF binding signal at all 45,350 p63 binding sites 
(left) and the p63 binding signal at all 12,116 CTCF binding sites (right). 
C Bandplots showing the p63 binding signal (left) and CTCF binding 
signal (right) at the 435 co-binding sites in both control and p63 mutant 
keratinocytes.
Additional file 2: Figure S2. Deregulated nucleosome organization at 
p63-bound and CTCF-bound Ctr-OCRs in p63 mutant keratinocytes. A 
Reads density of ATAC-seq at p63-bound Ctr-OCRs with different insert 
sizes in both control and p63 mutant keratinocytes. B Reads density of 
ATAC-seq at CTCF-bound Ctr-OCRs with different insert sizes in both 
control and p63 mutant keratinocytes.
Additional file 3: Figure S3. CTCF bound preferentially to Ctr-OCRs 
marked by H3K4me3. Ctr-OCRs are grouped into two categories accord-
ing to H3K4me3 signal, Ctr-OCRs with H3K4me3 (purple) and Ctr-OCRs 
without H3K4me3 (gray). CTCF ChIP-seq showed higher signal in Ctr-OCRs 
with H3K4me3, while p63 ChIP-seq showed higher signal in Ctr-OCRs 
without H3K4me3 in control keratinocytes. ***, p < 0.001, Wilcoxon signed-
rank test.
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